Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 05, 2007 18:06 ET | Source: Encysive Pharmaceuticals Inc.

Encysive Pharmaceuticals Receives Written Response From FDA On Its Request for Formal Dispute Resolution for THELIN (Sitaxsentan Sodium)

HOUSTON, Sept. 5, 2007 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals Inc. (Nasdaq:ENCY) today announced that it has received a written response from the U.S. Food and Drug Administration (FDA)...
September 04, 2007 07:00 ET | Source: Encysive Pharmaceuticals Inc.

Encysive Pharmaceuticals Announces Completion of Patient Enrollment in Phase II Diastolic Heart Failure Trial

HOUSTON, Sept. 4, 2007 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals (Nasdaq:ENCY) today announced that the Company has completed patient enrollment in the Phase II trial for Sitaxsentan sodium...
August 20, 2007 23:00 ET | Source: Encysive Pharmaceuticals Inc.

Encysive Pharmaceuticals Raises Approximately $15 Million in Equity Offering

HOUSTON, Aug. 20, 2007 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals Inc. (Nasdaq:ENCY) today announced that it has entered into definitive agreements with institutional accredited investors to...
August 06, 2007 16:15 ET | Source: Encysive Pharmaceuticals Inc.

Encysive Pharmaceuticals Files Request for Formal Dispute Resolution With U.S. FDA

HOUSTON, Aug. 6, 2007 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals Inc. (Nasdaq:ENCY) today announced that it has filed with the U.S. Food and Drug Administration (FDA) a request for formal dispute...
August 06, 2007 16:09 ET | Source: Encysive Pharmaceuticals Inc.

Encysive Pharmaceuticals Reports Second Quarter 2007 Financial Results

HOUSTON, Aug. 6, 2007 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals (Nasdaq:ENCY) today announced financial results for the second quarter ended June 30, 2007. "We continue to make progress...
July 23, 2007 07:00 ET | Source: Encysive Pharmaceuticals Inc.

Encysive Pharmaceuticals Announces Conference Call to Discuss Second Quarter 2007 Results

HOUSTON, July 23, 2007 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals Inc. (Nasdaq:ENCY) will hold an investor conference call on Monday, August 6, 2007 at 4:30 p.m. ET to discuss its second quarter...
July 17, 2007 07:00 ET | Source: Encysive Pharmaceuticals Inc.

Encysive Pharmaceuticals Retains Morgan Stanley to Assist in Review of Strategic Alternatives

HOUSTON, July 17, 2007 (PRIME NEWSWIRE) -- In connection with the matters discussed in the press release of June 15, Encysive Pharmaceuticals Inc. (Nasdaq:ENCY) today announced it has retained the...
July 13, 2007 07:00 ET | Source: Encysive Pharmaceuticals Inc.

Encysive Pharmaceuticals Provides Update for Thelin (Sitaxsentan Sodium)

HOUSTON, July 13, 2007 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals Inc. (Nasdaq:ENCY) today announced that the Company and officials from the U.S. Food and Drug Administration (FDA) held a formal...
July 09, 2007 16:06 ET | Source: Encysive Pharmaceuticals Inc.

Encysive Pharmaceuticals Announces Management Change

HOUSTON, July 9, 2007 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals Inc. (Nasdaq:ENCY) today announced that Gordon H. Busenbark has resigned as Chief Financial Officer of the Company effective July 13,...
June 25, 2007 16:54 ET | Source: Encysive Pharmaceuticals Inc.

Encysive Pharmaceuticals Appoints New Chief Executive and Announces Restructuring of Company Operations

HOUSTON, June 25, 2007 (PRIME NEWSWIRE) -- Encysive Pharmaceuticals Inc. (Nasdaq:ENCY) today announced that George W. Cole has been promoted to the position of President and Chief Executive Officer,...